Disapproval by IEC Sample Clauses

Disapproval by IEC. If, through no fault of Institution or Principal Investigator, the Trial is never initiated because of IEC disapproval, this Agreement will terminate immediately. b.
AutoNDA by SimpleDocs
Disapproval by IEC. If the Study is never initiated because of IEC disapproval, this Agreement will terminate immediately. (ii)
Disapproval by IEC. If, through no fault of Institution, the Trial is never initiated because of IEC disapproval, this Agreement will terminate immediately. a. Neschválenie nezávislou Etickou Komisiou. V prípade, že sa skúšanie nikdy nezačne kvôli jeho zamietnutiu zo strany nezávislej etickej komisie, bez akéhokoľvek zavinenia inštitúcie, táto zmluva bude okamžite ukončená.
Disapproval by IEC. If, through no fault of Institution or Principal Investigator, the Trial is never initiated because of IEC disapproval, this Agreement will terminate immediately. a. Neschválenie zo strany EK. Ak bez zavinenia Inštitúcie alebo Zodpovedného skúšajúceho Skúšanie nikdy nezačne z dôvodu neschválenia výborom EK, platnosť tejto dohody bude okamžite ukončená.
Disapproval by IEC. If, through no fault of Institution, the Trial is never initiated because of IEC disapproval, this Agreement will terminate immediately. a. Neschválenie zo strany NEV. Ak bez zavinenia Inštitúcie Skúšanie nikdy nezačne z dôvodu neschválenia výborom NEV, platnosť tejto dohody bude okamžite ukončená.
Disapproval by IEC. If, through no fault of Institution or Principal Investigator, the Trial is never initiated because of IEC disapproval, this Agreement will terminate immediately. a. Z amítnutí ze strany NEK Jestliže bez zavinění zdravotnického zařízení nebo hlavního zkoušejícího nebude klinické hodnocení zahájeno z důvodu zamítnutí ze strany NEK, bude tato smlouva s okamžitou platností ukončena.

Related to Disapproval by IEC

  • Approval by the Board Notwithstanding the foregoing, the Advisor may not take any action on behalf of the Company without the prior approval of the Board or duly authorized committees thereof if the Charter or Maryland General Corporation Law require the prior approval of the Board. If the Board or a committee of the Board must approve a proposed investment, financing or disposition or chooses to do so, the Advisor will deliver to the Board or committee, as applicable, all documents required by it to evaluate such investment, financing or disposition.

  • Waiver of Notice; Approval of Meeting Whenever notice to the Members is required to be given under this Agreement, a written waiver, signed by the Person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a Person at any such meeting of the Members shall constitute a waiver of notice of such meeting, except when the Person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the Members need be specified in any written waiver of notice unless so required by resolution of the Board. All waivers and approvals shall be filed with the Company records or made part of the minutes of the meeting.

  • Waiver of Notice; Approval of Meeting; Approval of Minutes The transactions of any meeting of Limited Partners, however called and noticed, and whenever held, shall be as valid as if it had occurred at a meeting duly held after regular call and notice, if a quorum is present either in person or by proxy. Attendance of a Limited Partner at a meeting shall constitute a waiver of notice of the meeting, except when the Limited Partner attends the meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened; and except that attendance at a meeting is not a waiver of any right to disapprove the consideration of matters required to be included in the notice of the meeting, but not so included, if the disapproval is expressly made at the meeting.

  • Approval Rights From the date hereof and until the Final Closing Date as described in Section 1(c), the Company shall not take any of the following actions without the prior written consent of the Purchaser, in its sole discretion:

  • Approval of Holders Whenever the consent or approval of Holders of a specified percentage of Registrable Securities is required hereunder, Registrable Securities held by the Company or its affiliates (as such term is defined in Rule 405 under the Securities Act) (other than the Initial Purchasers or subsequent Holders of Registrable Securities if such subsequent Holders are deemed to be such affiliates solely by reason of their holdings of such Registrable Securities) shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage.

  • Renewal Notice; Notification of Changes Subject to governing law, XOOM can renew this Agreement with new or revised Terms. XOOM will send you written notice at least (30) days before the end of the Term. The notice will specify the date by which you must advise XOOM if you do not want to renew your Agreement. If you do not advise XOOM by the specified date, this Agreement will automatically renew at the fixed rate or variable rate then in effect in accordance with the notice. XOOM reserves the right, with fifteen (15) days’ notice, to amend this Agreement to adjust its service to accommodate any change in regulations, law, tariff or other change in procedure required by any third party that may affect XOOM’s ability to continue to serve you under this Agreement.

  • Consent to Examination In connection with the performance by the Transfer Agent of the Delegated Duties, the Transfer Agent understands and acknowledges that the Fund remains responsible for assuring compliance with the USA PATRIOT Act and that the records the Transfer Agent maintains for the Fund relating to the AML Program may be subject, from time to time, to examination and/or inspection by federal regulators in order that the regulators may evaluate such compliance. The Transfer Agent hereby consents to such examination and/or inspection and agrees to cooperate with such federal examiners in connection with their review. For purposes of such examination and/or inspection, the Transfer Agent will use its best efforts to make available, during normal business hours and on reasonable notice all required records and information for review by such examiners.

  • Request for Notice; No Consent Required Where required or customary in the jurisdiction in which the Mortgaged Property is located, the original lender has filed for record a request for notice of any action by the related senior lienholder, and the Seller has notified such senior lienholder in writing of the existence of the Second Lien Loan and requested notification of any action to be taken against the Mortgagor by such senior lienholder. Either (a) no consent for the Second Lien Loan is required by the holder of the related first lien loan or (b) such consent has been obtained and is contained in the related Mortgage File;

  • Approval of Listing At the Closing Time, the Securities shall have been approved for listing on the New York Stock Exchange, subject only to official notice of issuance.

  • Notification of Compromise or Potential Compromise The compromise or potential compromise of Confidential Information must be reported to the DSHS Contact designated on the contract within one (1) business day of discovery. Contractor must also take actions to mitigate the risk of loss and comply with any notification or other requirements imposed by law or DSHS.

Time is Money Join Law Insider Premium to draft better contracts faster.